ANTI COAGULANT (2).pptx

Dr : AMER WAHAN
Anticoagulants
Anticoagulants
• ANTICOAGULANTS
• Blood coagulates when withdrawn from the vessel and anticoagulants
are used to prevent blood from clotting.
• Commonly used anticoagulants are
• I. Calcium chelating agents
• a. EDTA
• b. Double oxalate
• c . Sodium citrate solution
• d. Sodium fluoride
• II. Heparin
Calcium Chelating Agents
• Most of the anticoagulants used in the laboratory act by
binding calcium as an insoluble salt or soluble but un-ionized
salt.
• Since calcium is essential for many of the steps in the clotting
mechanism, chelation of calcium prevents clotting.
Calcium Chelating Agents
• Calcium chelating agents Anticoagulant Include:
• a. EDTA
• b. Double oxalate
• c . Sodium citrate solution
• d. Sodium fluoride
EDTA
(Ethylene Diamine Tetra Acetic acid)
EDTA (Ethylene Diamine Tetra Aceticacid): Commonly disodium or
tripotassium salts areused in the laboratory.
• Action:
They bind and remove free calcium ions from blood by chelation,
thereby preventingcoagulation.
• Advantages:
• it is the anticoagulant of choice for all cell counts and peripheral
smear.
• 1- EDTA preserves the morphology of the blood cells even upto 3
hours
• 2 preserves the cell counts upto 12 hours after collection of the blood.
EDTA
(Ethylene Diamine Tetra Aceticacid)
• Tripotassium salts of EDTA are more soluble and arepreferred for cell
counters than that of less soluble sodium salt.
• EDTA is used in solid form at concentration of 2 mg/mL of blood.
• Disadvantages:
• It is not suitable for coagulation studies
EDTA
(Ethylene Diamine Tetra Aceticacid)
• Alterations induced by EDTA:
• RBC: Red cells may assume spherocytic or macrocytic form.
• WBC: Morphologic changes take place in the neutrophils within 30 minutes of
blood collection.
• Platelets: They swell and disintegrate and a false decrease in their count may
be observed.
• Uses
• Cell counts: RBC count, total leukocyte count,, platelet count.
• peripheral smear
• Hemoglobin, HbF estimation and Hb electrophoresis.
b. Oxalate
• Potassium oxalate:
Most often used for chemical analysis.
• Shrinks RBCs and therefore notrecommended for packed cell volume (PCV),
erythrocyte sedimentation rate (ESR), orperipheral smear.
• Ammonium oxalate:
It causes swelling of RBCs and therefore not used for PCV, ESR or peripheral
smear.
Oxalate
• Double oxalate:
To balance the swelling effect of ammonium oxalate and the
shrinking effect of potassium oxalate,
the two are combined in a mixture in the ratio of 3 parts of
ammonium oxalate to 2 parts of potassium oxalate.
• Morphology of the blood cells is not well preserved; hence it has
now been replaced by EDTA.
• As it is toxic, it is not used as an anticoagulant for blood
transfusion.
• It is used in concentration of 2 mg/mL of blood.
Sodium Citrate
• Action:
• Sodium citrate binds with calcium ions in the blood to form a
soluble calcium citrate complex thus preventing coagulation of
blood.
• Disadvantages:
• Since it is used as a liquid which results in dilution of cellular
elements, it is not suitable for cell counts, Hb, etc.
Sodium Citrate
• Uses
1. Coagulation studies:
Either 3.8% trisodium citrate pentahydrate or 3.2% trisodium citrate
dihydrate solution is used for coagulation studies. One part of anticoagulant
is mixed with 9 parts of blood (1:9, i.e. ratio of 0.5 mL: 4.5 mL.)
2. ESR by Westergren method:
In the Westergren method of ESR estimation, ratio of 1:4 between citrate and
blood.
Sodium Citrate
1. Blood Bank:
• ACD Solution (acid citrate dextrose solution) was used as an anticoagulant in
blood banking. This has been replaced by citrate phosphate dextrose adenine
(CPDA).
Sodium Fluoride
• Sodium Fluoride
Sodium fluoride acts an antiglycolytic agent which inhibits the use of
glucose by blood cells.
• Use:
It is used for estimation of blood sugar.
Heparin
• Action:
Heparin acts as an anticoagulant by preventing conversion
of prothrombin to thrombin
• Method
Syringe is heparinised by taking 1 drop of heparin to wet the
inner surface of the syringe and the blood is collected.
Heparin
• Disadvantages
1. Expensive
2. Causes clumping of platelets and leukocytes, so it is not used for
automated cell counters.
3. Imparts bluish discoloration to the background of peripheral blood
smears.
4. Prevents coagulation for only a limited period of time and its effect
slowly disappears as the heparin is metabolized or neutralized in the
blood.
Heparin
•Uses
1. Osmotic fragility test done for diagnosis of
spherocytosis.
2. Red cell enzyme studies like G6PD and PK
deficiency.
3. Electrolyte estimation.
4. Arterial blood gas analysis.
1 of 17

Recommended

Osmotic fragility testOsmotic fragility test
Osmotic fragility testfateh11
21.7K views10 slides
AnticoagulantAnticoagulant
Anticoagulantchinoo281
46.9K views14 slides
AnticoagulantsAnticoagulants
AnticoagulantsGayathri Nair
4.5K views70 slides
APTT.pptxAPTT.pptx
APTT.pptxrajexh777
2K views8 slides

More Related Content

What's hot(20)

AnticoagulantsAnticoagulants
Anticoagulants
Priyanka Patel1.1K views
Automation in hematologyAutomation in hematology
Automation in hematology
Dr Siddartha34.1K views
Haematology Analyzer  Haematology Analyzer
Haematology Analyzer
APCER Life Sciences24.6K views
Esr  method, principle and interpretationEsr  method, principle and interpretation
Esr method, principle and interpretation
DeepshikhaVerma156.5K views
Microscopic examination of urineMicroscopic examination of urine
Microscopic examination of urine
SUNIL KUMAR PEDDANA7.6K views
Estimation of Serum UreaEstimation of Serum Urea
Estimation of Serum Urea
ASHIKH SEETHY23.2K views
AnticoagulantAnticoagulant
Anticoagulant
Wani Insha846 views
Blood collection and anticoagulantsBlood collection and anticoagulants
Blood collection and anticoagulants
Janani Mathialagan86.1K views
Anti coagulantsAnti coagulants
Anti coagulants
Richa Sharma38K views
HaemocytometryHaemocytometry
Haemocytometry
TasmiaZeb1746 views
Antocoagulant use in blood collectionAntocoagulant use in blood collection
Antocoagulant use in blood collection
Bhaikaka University422 views
Automation in haematologyAutomation in haematology
Automation in haematology
raj kumar12.4K views
Decalcification  Decalcification
Decalcification
Layal Fahad29.9K views
Blood collectionBlood collection
Blood collection
Angelica Nhoj Gemora68.8K views
Automation in Biochemistry (Autoanalyzers)Automation in Biochemistry (Autoanalyzers)
Automation in Biochemistry (Autoanalyzers)
Pradeep Singh Narwat36.4K views

Similar to ANTI COAGULANT (2).pptx(20)

Anticoagulants used in haematologyAnticoagulants used in haematology
Anticoagulants used in haematology
SUNIL KUMAR PEDDANA91.3K views
AntocoagulantsAntocoagulants
Antocoagulants
Amit kumar Singh813 views
AnticoagulantAnticoagulant
Anticoagulant
TasmiaZeb1255 views
Hema I Chapter 4_Anticoag.pptHema I Chapter 4_Anticoag.ppt
Hema I Chapter 4_Anticoag.ppt
deribew genetu30 views
Plasma expanders.pptxPlasma expanders.pptx
Plasma expanders.pptx
Kedar Bandekar947 views
instruments in pathology.pptxinstruments in pathology.pptx
instruments in pathology.pptx
AmanKothiwala181 views
Iv fluidsIv fluids
Iv fluids
BishukaAdhikari3.5K views
Counting of rbc and wbcCounting of rbc and wbc
Counting of rbc and wbc
Dr. Assad Al Imran 834 views
BLOOD PRODUCTS & PLASMA SUBSTITUTESBLOOD PRODUCTS & PLASMA SUBSTITUTES
BLOOD PRODUCTS & PLASMA SUBSTITUTES
KMCH COLLEGE OF PHARMACY30.1K views
Artefaccts in hemat part 1Artefaccts in hemat part 1
Artefaccts in hemat part 1
DrShrikant Sonune1.4K views
Fluid and electrolytesFluid and electrolytes
Fluid and electrolytes
Ram Yadav300 views

More from ssuser668f10(20)

Glossary_ST_NAR_26_A.pdf medical Glossary_ST_NAR_26_A.pdf medical
Glossary_ST_NAR_26_A.pdf medical
ssuser668f107 views
Blood cell morphology.pptBlood cell morphology.ppt
Blood cell morphology.ppt
ssuser668f10134 views
5                     Leukopoiesis (1).pdf5                     Leukopoiesis (1).pdf
5 Leukopoiesis (1).pdf
ssuser668f102.8K views
1-1.pdf1-1.pdf
1-1.pdf
ssuser668f1081 views
الاحماض النوويه1.pptالاحماض النوويه1.ppt
الاحماض النوويه1.ppt
ssuser668f1060 views
ASO test.pptASO test.ppt
ASO test.ppt
ssuser668f101.9K views
Clinical enzymology.pptClinical enzymology.ppt
Clinical enzymology.ppt
ssuser668f10328 views
جميل الغيثي.en.ar.pptxجميل الغيثي.en.ar.pptx
جميل الغيثي.en.ar.pptx
ssuser668f102 views
بكتيريا.en.ar.pptxبكتيريا.en.ar.pptx
بكتيريا.en.ar.pptx
ssuser668f104 views
cardiac_function_test_2018.pptcardiac_function_test_2018.ppt
cardiac_function_test_2018.ppt
ssuser668f1084 views
Neutralization--TV (1).pptxNeutralization--TV (1).pptx
Neutralization--TV (1).pptx
ssuser668f10116 views
b.colib.coli
b.coli
ssuser668f1014 views
EpidemiologyOverview.pptEpidemiologyOverview.ppt
EpidemiologyOverview.ppt
ssuser668f10268 views
1584610537.pptx1584610537.pptx
1584610537.pptx
ssuser668f109 views
safety_chem_course_en.en.ar.pdfsafety_chem_course_en.en.ar.pdf
safety_chem_course_en.en.ar.pdf
ssuser668f1020 views

Recently uploaded(20)

Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61318 views
Referral-system_April-2023.pdfReferral-system_April-2023.pdf
Referral-system_April-2023.pdf
manali905434 views
NMP-4.pptxNMP-4.pptx
NMP-4.pptx
Sai Sailesh Kumar Goothy32 views
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptxINDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
Prithivirajan Senthilkumar15 views
HEAT TRANSFER.pptxHEAT TRANSFER.pptx
HEAT TRANSFER.pptx
AneriPatwari178 views
melani glossophobia.pdfmelani glossophobia.pdf
melani glossophobia.pdf
Paygeon8 views
NMP-5.pptxNMP-5.pptx
NMP-5.pptx
Sai Sailesh Kumar Goothy21 views
 CAPSULE CAPSULE
CAPSULE
Ganapathi Vankudoth60 views
HYDROCOLLATOR PACK by Dr. Aneri.pptxHYDROCOLLATOR PACK by Dr. Aneri.pptx
HYDROCOLLATOR PACK by Dr. Aneri.pptx
AneriPatwari106 views
NMP-6.pptxNMP-6.pptx
NMP-6.pptx
Sai Sailesh Kumar Goothy41 views
Allergy Shots - BasicsAllergy Shots - Basics
Allergy Shots - Basics
lesliemspeer7 views
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed618 views

ANTI COAGULANT (2).pptx

  • 1. Dr : AMER WAHAN
  • 3. Anticoagulants • ANTICOAGULANTS • Blood coagulates when withdrawn from the vessel and anticoagulants are used to prevent blood from clotting. • Commonly used anticoagulants are • I. Calcium chelating agents • a. EDTA • b. Double oxalate • c . Sodium citrate solution • d. Sodium fluoride • II. Heparin
  • 4. Calcium Chelating Agents • Most of the anticoagulants used in the laboratory act by binding calcium as an insoluble salt or soluble but un-ionized salt. • Since calcium is essential for many of the steps in the clotting mechanism, chelation of calcium prevents clotting.
  • 5. Calcium Chelating Agents • Calcium chelating agents Anticoagulant Include: • a. EDTA • b. Double oxalate • c . Sodium citrate solution • d. Sodium fluoride
  • 6. EDTA (Ethylene Diamine Tetra Acetic acid) EDTA (Ethylene Diamine Tetra Aceticacid): Commonly disodium or tripotassium salts areused in the laboratory. • Action: They bind and remove free calcium ions from blood by chelation, thereby preventingcoagulation. • Advantages: • it is the anticoagulant of choice for all cell counts and peripheral smear. • 1- EDTA preserves the morphology of the blood cells even upto 3 hours • 2 preserves the cell counts upto 12 hours after collection of the blood.
  • 7. EDTA (Ethylene Diamine Tetra Aceticacid) • Tripotassium salts of EDTA are more soluble and arepreferred for cell counters than that of less soluble sodium salt. • EDTA is used in solid form at concentration of 2 mg/mL of blood. • Disadvantages: • It is not suitable for coagulation studies
  • 8. EDTA (Ethylene Diamine Tetra Aceticacid) • Alterations induced by EDTA: • RBC: Red cells may assume spherocytic or macrocytic form. • WBC: Morphologic changes take place in the neutrophils within 30 minutes of blood collection. • Platelets: They swell and disintegrate and a false decrease in their count may be observed. • Uses • Cell counts: RBC count, total leukocyte count,, platelet count. • peripheral smear • Hemoglobin, HbF estimation and Hb electrophoresis.
  • 9. b. Oxalate • Potassium oxalate: Most often used for chemical analysis. • Shrinks RBCs and therefore notrecommended for packed cell volume (PCV), erythrocyte sedimentation rate (ESR), orperipheral smear. • Ammonium oxalate: It causes swelling of RBCs and therefore not used for PCV, ESR or peripheral smear.
  • 10. Oxalate • Double oxalate: To balance the swelling effect of ammonium oxalate and the shrinking effect of potassium oxalate, the two are combined in a mixture in the ratio of 3 parts of ammonium oxalate to 2 parts of potassium oxalate. • Morphology of the blood cells is not well preserved; hence it has now been replaced by EDTA. • As it is toxic, it is not used as an anticoagulant for blood transfusion. • It is used in concentration of 2 mg/mL of blood.
  • 11. Sodium Citrate • Action: • Sodium citrate binds with calcium ions in the blood to form a soluble calcium citrate complex thus preventing coagulation of blood. • Disadvantages: • Since it is used as a liquid which results in dilution of cellular elements, it is not suitable for cell counts, Hb, etc.
  • 12. Sodium Citrate • Uses 1. Coagulation studies: Either 3.8% trisodium citrate pentahydrate or 3.2% trisodium citrate dihydrate solution is used for coagulation studies. One part of anticoagulant is mixed with 9 parts of blood (1:9, i.e. ratio of 0.5 mL: 4.5 mL.) 2. ESR by Westergren method: In the Westergren method of ESR estimation, ratio of 1:4 between citrate and blood.
  • 13. Sodium Citrate 1. Blood Bank: • ACD Solution (acid citrate dextrose solution) was used as an anticoagulant in blood banking. This has been replaced by citrate phosphate dextrose adenine (CPDA).
  • 14. Sodium Fluoride • Sodium Fluoride Sodium fluoride acts an antiglycolytic agent which inhibits the use of glucose by blood cells. • Use: It is used for estimation of blood sugar.
  • 15. Heparin • Action: Heparin acts as an anticoagulant by preventing conversion of prothrombin to thrombin • Method Syringe is heparinised by taking 1 drop of heparin to wet the inner surface of the syringe and the blood is collected.
  • 16. Heparin • Disadvantages 1. Expensive 2. Causes clumping of platelets and leukocytes, so it is not used for automated cell counters. 3. Imparts bluish discoloration to the background of peripheral blood smears. 4. Prevents coagulation for only a limited period of time and its effect slowly disappears as the heparin is metabolized or neutralized in the blood.
  • 17. Heparin •Uses 1. Osmotic fragility test done for diagnosis of spherocytosis. 2. Red cell enzyme studies like G6PD and PK deficiency. 3. Electrolyte estimation. 4. Arterial blood gas analysis.